Arctic Bioscience — Regulatory Filings 2022

Sep 13, 2022

Arctic Bioscience - Invitation to capital markets update

Arctic Bioscience - Invitation to capital markets update

Arctic Bioscience is pleased to invite investors, analysts, media and other

stakeholders to a Capital Markets Update on 21 September 2022 in Oslo.

Presentations will be held by Arctic Bioscience management and external experts.

The presentations and the following Q&A session will be held in Norwegian. The

session will end with serving of a light lunch and mingling.

The event will take place at Flyt Conference Centre, Haakon VIIs gate 2 from

10.00 - 12.00 CEST

A recording of the event will be available on the company's web site after the

event.

To registrate your participance for the event, please send an email to Jone R.

Slinning: jone@arctic-bioscience.com.

Tentative agenda

· Introduction and company presentation - Christer Valderhaug, CEO Arctic

Bioscience

· Psoriasis symptom relief through Herring Caviar Oil - Dr. Kåre Steinar

Tveit, Chief Physician Haukeland University Hospital

· Arctic Bioscience Pharmaceutical Development Program  - Runhild Gammelsæter,

Medical Director Arctic Bioscience

· Brain development in extremely premature infants - Smerud Medical Research -

Knut Smerud, Founder & CEO Smerud Medical Research

· DHA, Alfa & Omega for The Brain - Ole Petter Hjelle, MD PhD

· Closing remarks & Q&A - CEO Christer Valderhaug, Medical Director Runhild

Gammelsæter, CFO Jone R. Slinning

For further information, please contact

Christer L. Valderhaug, CEO

Mobile: +47 920 84 601

Email: christer@arctic-bioscience.com

Jone R. Slinning, CFO

Mobile: +47 948 75 469

Email: jone@arctic-bioscience.com

About Arctic Bioscience

Arctic Bioscience is a biotech company developing and commercializing

pharmaceutical and nutraceutical products based on unique bioactive marine

compounds.

The company is developing HRO350 - a novel oral drug candidate. HRO350 is being

developed for treatment of patients with mild-to-moderate psoriasis. This is a

large patient group in need of new effective medicines with beneficial safety

profile.

Nutraceuticals from Arctic Bioscience are sold globally as bulk ingredients as

well as finished goods under the ROMEGA® brand.

Arctic Bioscience is led by a team of highly competent people with experience in

developing marine oils and experience from global pharmaceutical companies.